ECMatrix
ECMatrix aims to develop ReGenDisc, a new-generation, revolutionary and cost-effective synthetic scaffold that, when implanted, initiates permanent, natural cartilage regeneration in the spine.
| Startup type: | Competition Entry |
| Status: | Active |
| Publicity: | Stealth mode. No media please. |
OUR NEWS
Long ago
|
26 February 2009
Salvatore Mascia joined the team. |
|
Major in pharmaceutical science and engineering. Industrial experience gained with Merck and Novartis. President of the Cambridge University Technology and Enterprise Club. Eager to pursue an entrepreneurship career within the pharma/biotech space.
|
|
|
26 February 2009
Francesco Renzo joined the team. |
|
BSc and MSc in Finance from Bocconi University. Currently pursuing MBA at MIT. Worked at McKinsey and Company for 2 years.
|
THINGS WE NEED
The ECMatrix team hasn't posted any needs yet.
COMMENTS (0)
Team (6)
View all-
Benjamin Geisler
Research-doctor, health economics/decision analysis, interested in discussing value and quality of health care
-
Salvatore Mascia
Major in pharmaceutical science and engineering. Industrial experience gained with Merck and Novartis. President of the Cambridge University Technology and Enterprise Club. Eager to pursue an entrepreneurship career within the pharma/biotech space.
-
-
Francesco Renzo
BSc and MSc in Finance from Bocconi University. Currently pursuing MBA at MIT. Worked at McKinsey and Company for 2 years.